1. Academic Validation
  2. The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial

The human CXC chemokine granulocyte chemotactic protein 2 (GCP-2)/CXCL6 possesses membrane-disrupting properties and is antibacterial

  • Antimicrob Agents Chemother. 2008 Jul;52(7):2599-607. doi: 10.1128/AAC.00028-08.
Helena M Linge 1 Mattias Collin Pontus Nordenfelt Matthias Mörgelin Martin Malmsten Arne Egesten
Affiliations

Affiliation

  • 1 Divisions of Infection, Department of Clinical Sciences Lund, Lund University, SE-221 84 Lund, Sweden. hlinge@nshs.edu
Abstract

Granulocyte chemotactic protein 2 (GCP-2)/CXCL6 is a CXC chemokine expressed by macrophages and epithelial and mesenchymal cells during inflammation. Through binding and activation of its receptors (CXCR1 and CXCR2), it exerts neutrophil-activating and angiogenic activities. Here we show that GCP-2/CXCL6 itself is Antibacterial. Antibacterial activity against gram-positive and gram-negative pathogenic bacteria of relevance to mucosal infections was seen at submicromolar concentrations (minimal bactericidal concentration at which 50% of strains tested were killed, 0.063 +/- 0.01 to 0.37 +/- 0.03 muM). In killed bacteria, GCP-2/CXCL6 associated with Bacterial surfaces, which showed membrane disruption and leakage. A structural prediction indicated the presence of three antiparallel NH(2)-terminal beta-sheets and a short amphipathic COOH-terminal alpha-helix; the latter feature is typical of Antimicrobial Peptides. However, when the synthetic derivatives corresponding to the NH(2)-terminal (50 Amino acids) and COOH-terminal (19 Amino acids, corresponding to the putative alpha-helix) regions were compared, higher Antibacterial activity was observed for the NH(2)-terminus-derived peptide, indicating that the holopeptide is necessary for full Antibacterial activity. An artificial model of Bacterial membranes confirmed these findings. The helical content of GCP-2/CXCL6 in the presence or absence of lipopolysaccharide or negatively charged membranes was studied by circular dichroism. As with many Antibacterial peptides, membrane disruption by GCP-2/CXCL6 was dose-dependently reduced in the presence of NaCl, which, we here demonstrate, inhibited the binding of the peptide to the Bacterial surface. Compared with CXC Chemokines ENA-78/CXCL5 and NAP-2/CXCL7, GCP-2/CXCL6 showed a 90-fold-higher Antibacterial activity. Taken together, GCP/CXCL6, in addition to its chemotactic and angiogenic properties, is likely to contribute to direct Antibacterial activity during localized Infection.

Figures
Products